Scitop Bio released its performance for the first three quarters, with a net profit attributable to the parent company of 76.232 million yuan, an increase of 7.08%
Scitop Bio released its Q3 2025 report, with revenue for the first three quarters reaching 267 million yuan, a year-on-year increase of 22.25%; net profit attributable to the parent company was 76.232 million yuan, a year-on-year increase of 7.08%; net profit excluding non-recurring gains and losses was 67.078 million yuan, a year-on-year increase of 9.79%; basic earnings per share were 0.29 yuan
According to the Zhitong Finance APP, Scitop Bio (300858.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 267 million yuan, a year-on-year increase of 22.25%. The net profit attributable to shareholders of the listed company was 76.232 million yuan, a year-on-year increase of 7.08%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 67.078 million yuan, a year-on-year increase of 9.79%. The basic earnings per share were 0.29 yuan
